Pharvaris N.V.
PHVS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001830487
In the last 90 days, Pharvaris N.V. insiders filed 0 open-market purchases and 20 sales; 125 institutions reported holding it in 13F filings for Q2 2026, worth $2.23B in total; Viking Global Investors is the only superinvestor holding it.
Superinvestors holding PHVS, Q2 2026
1 superinvestor reports holding Pharvaris N.V. on Form 13F, worth $126.3M in total. Weight is Pharvaris N.V.'s share of each 13F portfolio; actions compare shares with Q1 2026.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| Viking Global InvestorsAndreas Halvorsen | 0.4% | 3,653,310 | $126.3M | Unchanged |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of PHVS each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q1 2024
1 superinvestor holding at quarter end
- Reduced
- Viking Global Investors (−0.1%)
Q4 2023
1 superinvestor holding at quarter end
- Added
- Viking Global Investors (+13.2%)
Q4 2022
1 superinvestor holding at quarter end
- Added
- Viking Global Investors (+29.4%)
Q3 2022
1 superinvestor holding at quarter end
- Added
- Viking Global Investors (+0.2%)
Q2 2022
1 superinvestor holding at quarter end
- Added
- Viking Global Investors (+0.5%)
Q1 2022
1 superinvestor holding at quarter end
- Added
- Viking Global Investors (+1.0%)
Q4 2021
1 superinvestor holding at quarter end
- Added
- Viking Global Investors (+2.7%)
Q2 2021
1 superinvestor holding at quarter end
- Reduced
- Viking Global Investors (−1.2%)